logo

For the Inventor, By the Inventor

La Chaux-de-Fonds, Switzerland

Ichnos Sciences Sa


USPTO Granted Patents = 13

% Expired Patents = 23.1



Trademarks = 7

Forward Citations = 8

Loading Chart...
Loading Chart...

37 inventors (with patents filed for the assignee):

goldMedal Samuel Hou (7 out of 12 patents)

silverMedal Stanislas Blein (5 out of 15 patents)

bronzeMedal Rami Lissilaa (5 out of 7 patents)

4.  Romain Ollier (5 out of 6 patents)

5.  Jonathan Albert Back (4 out of 6 patents)

6.  Darko Skegro (4 out of 13 patents)

7.  Neelima Khairatkar-Joshi (2 out of 44 patents)

8.  Jeremy Loyau (2 out of 5 patents)

9.  Antoine Attinger (2 out of 4 patents)

10.  Sonia Letestu (2 out of 2 patents)

11.  Lionel Duarte (2 out of 2 patents)

12.  Filipa Abrantes (2 out of 2 patents)

13.  Laure Cahuzac (2 out of 2 patents)

14.  Thierry Monney (2 out of 5 patents)

15.  Nagarajan Muthukaman (1 out of 8 patents)


13 patents:

1. 12692314 - CD3/BCMA/CD38 Trispecific Antibodies (2026-07-28),
2. 12351602 - Methods of inactivating viral contaminants (2025-07-08),
3. 12281169 - Antibodies that bind to OX40 and their uses (2025-04-21),
4. 12006367 - CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production (2024-06-11),
5. 11970539 - Antibodies that bind to IL1RAP and uses thereof (2024-04-30),
6. 11891454 - Production of T cell retargeting hetero-dimeric immunoglobulins (2024-02-06),
7. 11884700 - Methods of inactivating viral contaminants (2024-01-30),
8. 11851502 - Production of T cell retargeting hetero-dimeric immunoglobulins (2023-12-26),
9. 11773166 - CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production (2023-10-03),
10. 11407839 - Antibodies that bind to OX40 and their uses (2022-08-09),
11. 10821100 - Triazolone compounds as mPGES-1 inhibitors (2020-11-03),
12. 10758517 - mPGES-1 inhibitor for the treatment of osteoarthritis pain (2020-09-01),
13. 10640564 - Antibodies that bind to CCR6 and their uses (2020-05-05),
Ichnos Sciences Sa is a biopharmaceutical company dedicated to developing innovative treatments for patients with unmet medical needs. With a focus on research and development, Ichnos Sciences is committed to bringing novel therapies to market to improve the lives of patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

13 Patents

#15 in La Chaux-de-Fonds

#877 in Switzerland

#44,914 in the World

La Chaux-de-Fonds, CH
La Chaux-de-Fonds, Switzerland

Ichnos Sciences Sa

Forward Citations = 8

37 inventors:

goldMedal Samuel Hou (7 out of 12 patents)

silverMedal Stanislas Blein (5 out of 15 patents)

bronzeMedal Rami Lissilaa (5 out of 7 patents)

4.  Romain Ollier (5 out of 6 patents)

5.  Jonathan Albert Back (4 out of 6 patents)

Please report any incorrect information to [email protected]
Loading…